MLTA3698A Uses, Dosage, Side Effects and more
MLTA3698A is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis).
| Attribute | Details |
|---|---|
| Trade Name | MLTA3698A |
| Generic | Pateclizumab |
| Pateclizumab Other Names | MLTA3698A, Pateclizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
